BIOMAT Database Logo BIOMAT Database Logo

Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA). 1999

M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
DuPont Pharmaceuticals Company, Experimental Station, Wilmington, DE 19880-0500, USA.

Two series of benzoxazinones differing in the aromatic substitution pattern were prepared and evaluated as HIV-1 reverse transcriptase inhibitors. The 5-fluoro (5a-d) and 6-nitro (5e-h) substituted compounds displayed activity comparable or better than Efavirenz, the lead structure of the series.

UI MeSH Term Description Entries
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D048588 Benzoxazines OXAZINES with a fused BENZENE ring. Benzoxazine,Benzoxazinoid,Benzoxazinone,Benzoxazinones,Benzoxazinoids
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.
June 2001, Bioorganic & medicinal chemistry letters,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chain.
May 2001, Bioorganic & medicinal chemistry letters,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Designing hypothesis of substituted benzoxazinones as HIV-1 reverse transcriptase inhibitors: QSAR approach.
October 2012, Journal of enzyme inhibition and medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives.
April 1997, Drug design and discovery,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Synthesis and Anti-HIV-1 Evaluation of Some Novel MC-1220 Analogs as Non-Nucleoside Reverse Transcriptase Inhibitors.
May 2016, Archiv der Pharmazie,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Synthesis and evaluation of oligo-1,3-thiazolecarboxamide derivatives as HIV-1 reverse transcriptase inhibitors.
May 2000, Bioorganic & medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
April 2009, Bioorganic & medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
New Efavirenz Derivatives and 1,2,3-Triazolyl-phosphonates as Inhibitors of Reverse Transcriptase of HIV-1.
January 2018, Current topics in medicinal chemistry,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Synthesis of certain heterodimers expected as HIV-1 reverse transcriptase inhibitors.
January 2003, Nucleosides, nucleotides & nucleic acids,
M Patel, and R J McHugh, and B C Cordova, and R M Klabe, and S Erickson-Viitanen, and G L Trainor, and S S Ko
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
June 2014, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!